Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects

Xuemei He,1 Kazuya Narushima,2 Masahiro Kojima,2 Chisato Nagai,2 Kexin Li1 1Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Applic...

Descrizione completa

Dettagli Bibliografici

Autori principali:	He X, Narushima K, Kojima M, Nagai C, Li K
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2024-02-01
Serie:	Drug Design, Development and Therapy
Soggetti:	evocalcet calcimimetic agents secondary hypoparathyroidism pharmacokinetic pharmacodynamic safety
Accesso online:	https://www.dovepress.com/pharmacokinetics-pharmacodynamics-and-safety-of-evocalcet-khk7580-a-no-peer-reviewed-fulltext-article-DDDT
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!